Development of malignancy after treatment of idiopathic membranous nephropathy

Kidney Int. 2004 Jul;66(1):464; author reply 464-5. doi: 10.1111/j.1523-1755.2004.669_11.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Glomerulonephritis, Membranous / complications*
  • Glomerulonephritis, Membranous / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Neoplasms / chemically induced
  • Neoplasms / etiology*

Substances

  • Immunosuppressive Agents